Cellerant Pipeline

Cellerant has three major products under development:

• CLT-001, a highly purified hematopoietic (blood forming) stem cell product with applications in the treatment of cancer and sickle cell disease;
  
• Antibody therapy targeting Cancer Stem Cells.
• CLT-008, an off-the-shelf cell-based medicine which can treat neutropenia due to chemotherapy or radiation exposure; and